Astellas Pharma
Company Details
Linkedin ID:
astellaspharmainc
Website:
Employees number:
11,951
Number of followers:
651,651
NAICS:
3254
Industry Type:
Homepage:
astellas.com
IP Addresses:
0
Company ID:
AST_1093412
Scan Status:
In-progress
Astellas Pharma Company CyberSecurity Posture
astellas.com
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines
Astellas Pharma A.I CyberSecurity Scoring
Astellas Pharma Risk Score (AI oriented)Between 750 and 799
Astellas Pharma
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Astellas Pharma Global Score (TPRM)XXXX
Astellas Pharma
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Astellas Pharma Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Astellas Pharma Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Astellas Pharma
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Astellas Pharma in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Astellas Pharma in 2025.
Incident Types Astellas Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Astellas Pharma in 2025.
Incident History — Astellas Pharma (X = Date, Y = Severity)
Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries
Astellas Pharma Company Subsidiaries
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines
Loading...
Astellas Pharma Similar Companies
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important
Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage
Dr. Reddy's Laboratories
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics
Hyderabad Pharmaceutical Congress Committee
HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketi
MACLEODS PHARMACEUTICALS LTD.
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
AUROBINDO PHARMA LTD
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
Intas Pharmaceuticals
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc
Ipca Laboratories Limited
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need
.png)
Astellas Pharma CyberSecurity News
October 07, 2025 03:05 PM
Astellas Careers: Work With Purpose in Science & Innovation
Explore Astellas careers and job openings worldwide, and join a team driven by science, collaboration, and a mission to improve patients' lives.
September 23, 2024 07:00 AM
The White House, Microsoft, SaS, Foley Hoag & Astellas Offer AI Guidance to Investors. Part One: The Present
Before companies and investors look towards the future, they must first understand the opportunities and challenges AI presents to them.
June 06, 2023 07:00 AM
Eisai hit with ransomware attack, launches investigation into possible data leaks
Eisai is the latest drugmaker to be hit with a ransomware attack. The Japanese company said it “immediately” set up a company-wide task force after suffering a...
March 10, 2023 08:00 AM
Fierce Pharma Asia—Leqembi's priority review; Enhertu's broad trial win; Cipla's FDA censure
Leqembi scored an FDA priority review. Enhertu showed pan-tumor activity in a key trial. The FDA sent a long Form 483 to Cipla. Plus more.
January 30, 2023 08:00 AM
Microsoft surpasses $20B in security revenue as enterprise customers consolidate
The company's cybersecurity business is growing, but CEO Satya Nadella warned that customers, in an uncertain economy, are exercising...
February 24, 2022 08:00 AM
Accenture Helping Astellas Pharma Create Next-Generation Cloud-Based IT Core Platform for Advanced Real-Time Decision Making
TOKYO; Feb. 24, 2022 - Accenture (NYSE: ACN) helped Astellas Pharma Inc. create a cloud-based core IT platform that serves as the foundation...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Astellas Pharma CyberSecurity History Information
Official Website of Astellas Pharma
The official website of Astellas Pharma is http://www.astellas.com/.
Astellas Pharma’s AI-Generated Cybersecurity Score
According to Rankiteo, Astellas Pharma’s AI-generated cybersecurity score is 797, reflecting their Fair security posture.
How many security badges does Astellas Pharma’ have ?
According to Rankiteo, Astellas Pharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Astellas Pharma have SOC 2 Type 1 certification ?
According to Rankiteo, Astellas Pharma is not certified under SOC 2 Type 1.
Does Astellas Pharma have SOC 2 Type 2 certification ?
According to Rankiteo, Astellas Pharma does not hold a SOC 2 Type 2 certification.
Does Astellas Pharma comply with GDPR ?
According to Rankiteo, Astellas Pharma is not listed as GDPR compliant.
Does Astellas Pharma have PCI DSS certification ?
According to Rankiteo, Astellas Pharma does not currently maintain PCI DSS compliance.
Does Astellas Pharma comply with HIPAA ?
According to Rankiteo, Astellas Pharma is not compliant with HIPAA regulations.
Does Astellas Pharma have ISO 27001 certification ?
According to Rankiteo,Astellas Pharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Astellas Pharma
Astellas Pharma operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Astellas Pharma
Astellas Pharma employs approximately 11,951 people worldwide.
Subsidiaries Owned by Astellas Pharma
Astellas Pharma presently has no subsidiaries across any sectors.
Astellas Pharma’s LinkedIn Followers
Astellas Pharma’s official LinkedIn profile has approximately 651,651 followers.
NAICS Classification of Astellas Pharma
Astellas Pharma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Astellas Pharma’s Presence on Crunchbase
No, Astellas Pharma does not have a profile on Crunchbase.
Astellas Pharma’s Presence on LinkedIn
Yes, Astellas Pharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/astellaspharmainc.
Cybersecurity Incidents Involving Astellas Pharma
As of December 11, 2025, Rankiteo reports that Astellas Pharma has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Astellas Pharma has an estimated 5,413 peer or competitor companies worldwide.
Astellas Pharma CyberSecurity History Information
How many cyber incidents has Astellas Pharma faced ?
Total Incidents: According to Rankiteo, Astellas Pharma has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Astellas Pharma ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=astellaspharmainc' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
